NCT06068686Completed
Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients
Effect of Vildagliptin Versus Glimepiride on Copeptin and Fetuin-A in Type 2 Diabetic Patients
Source: ClinicalTrials.gov · Last updated 4 Feb 2025
Brief summary (registry, in English)
The aim of this study is to evaluate the effect of vildagliptin on copeptin in comparison to glimepiride, and whether copeptin could be used as a marker for the efficacy of vildagliptin in type 2 diabetes mellitus patients, and how copeptin correlates with other diabetic and cardiac markers.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 29 Sept 2023
- Start date
- 1 Oct 2022
- Primary completion date
- 30 Nov 2024
- Lead sponsor
- Damanhour University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06068686
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 1 Oct 2022 to the primary completion date, 30 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planned surgical intervention.
- Addition of any anti-diabetic medications or insulin during follows up.
- Therapy with any diuretic or a medication affecting the RAAS.
Other illness
- Hepatic impairment.
- Active malignancy.
- Any signs of hypersensitivity or contraindication to study drugs developed.
- Chronic inflammatory disease (i.e. inflammatory bowel disease, lupus, inflammatory arthritis, rheumatoid arthritis) or chronic infection (i.e. chronic diabetic foot infection).
- Cardiac disease.
- Renal impairment.
- History of T1DM, SIAD, or diabetes insipidus.
Other
- Pregnancy, lactation or child-bearing potential.
Who the study is looking for
- 70 uncontrolled adult patients with Type II-diabetes mellitus
Age in the registry: 35 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes. Coordinator of this site? Confirm its status | Damanhūr | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.